par Lambrechts, Diether;Poesen, Koen;Fernández-Santiago, R;Al-Chalabi, Ammar;Del Bo, R;Van Vught, P W J;Khan, S;Marklund, S L;Brockington, A;Van Marion, Ingrid
;Anneser, J;Shaw, C;Ludolph, A C;Leigh, N P;Comi, Giacomo Pietro;Gasser, Thomas;Shaw, Peter John;Morrison, K E;Andersen, Peter M;Van den Berg, L H;Thijs, V;Siddique, T;Robberecht, Wim;Carmeliet, Peter
Référence Journal of medical genetics, 46, 12, page (840-846)
Publication Publié, 2009
;Anneser, J;Shaw, C;Ludolph, A C;Leigh, N P;Comi, Giacomo Pietro;Gasser, Thomas;Shaw, Peter John;Morrison, K E;Andersen, Peter M;Van den Berg, L H;Thijs, V;Siddique, T;Robberecht, Wim;Carmeliet, PeterRéférence Journal of medical genetics, 46, 12, page (840-846)
Publication Publié, 2009
Article révisé par les pairs
| Résumé : | Background: Targeted delivery of the angiogenic factor, vascular endothelial growth factor (VEGF), to motor neurons prolongs survival in rodent models of amyotrophic lateral sclerosis (ALS), while mice expressing reduced VEGF concentrations develop motor neuron degeneration reminiscent of ALS, raising the question whether VEGF contributes to the pathogenesis of ALS. An initial association study reported that VEGF haplotypes conferred increased susceptibility to ALS in humans, but later studies challenged this initial finding.Methods and findings: A meta-analysis was undertaken to critically reappraise whether any of the three common VEGF gene variations (-2578C/A, -1154G/A and -634G/C) increase the risk of ALS. Over 7000 subjects from eight European and three American populations were included in the analysis. Pooled odds ratios were calculated using fixed-effects and random-effects models, and four potential sources of heterogeneity (location of disease onset, gender, age at disease onset and disease duration) were assessed. After correction, none of the genotypes or haplotypes was significantly associated with ALS. Subgroup analysis by gender revealed, however, that the -2578AA genotype, which lowers VEGF expression, increased the risk of ALS in males (OR |



